Meeting Banner
Abstract #0168

MRI Describes Mitigation of Radiation Necrosis

MAGNA25Xiaoyu Jiang1, John A. Engelbach2, Jeremy Cates3, Dinesh K. Thotala3, Robert E. Drzymala3, Dennis E. Hallahan3, Joseph JH Ackerman2, Joel R. Garbow2

1Chemistry, Washington University in St. louis, St. louis, MO, United States; 2Radiology, Washington University in St. louis, St. louis, MO, United States; 3Radiation Oncology, Washington University in St. louis, St. louis, MO, United States

Radiation necrosis is a severe, but late occurring, injury to normal tissue, within and surrounding a radiation treatment field. Increases in vascular permeability (leakiness) and acute vascular apoptosis have both been suggested as possible causes of radiation necrosis. Bevacizumab may help to repair leaky capillaries and thereby mitigate radiation necrosis. Specific inhibitors of GSK-3β, a serine/threonine kinase, are known to ameliorate apoptosis. We have recently developed a novel mouse model of radiation necrosis using Gamma Knife irradiation. Here, we use small-animal MRI to measure the mitigation of radiation necrosis by bevacizumab and SB415286, an inhibitor of GSK-3β, in this mouse model.

Keywords

accurately action acute approximately arrow attempts barrier beginning beta blood blue bottom brain breakdown cancer capillaries caused cell characterization chosen classic cohort cohorts collected colon consistent constructed contiguous contrast control cord cranial culture cutoff death define delay describes development difficult direct distribution dose dosing early either electric endothelial enhanced equipped exceeding expression features gamma gradients greatly hemisphere histogram histograms hope hypoxia identify in vivo indicated indicating inhibition inhibitor initially injury innovative intensity irradiated irradiation john knife laboratory late latter majority malignant measure metastatic mice mitigate mitigation model mouse much necrosis normalized novel onset patients performance period phys pixel pixels plot post power prevent progress progresses progression radiation rapidly recapitulates received recent reduced reduction repair reports representative resistance responsible routinely sacrificed scanner schemes serve served severe significantly slices slower spin subsequent substantially suggested surrounding survival symmetric therapy threshold tissue together treated treatment trials tumors twice type understand unit untreated vascular volumes weekly weeks wild